Online Finasteride Prescription — 2026 Provider Comparison
Finasteride is the FDA-approved standard of care for male pattern hair loss. Telehealth has dramatically reduced the cost barrier and made compounded multi-active topicals (combining finasteride with minoxidil and other actives) widely accessible.
A 5-alpha reductase inhibitor that lowers DHT, the hormone that drives androgenetic alopecia.
Men with male pattern hair loss seeking a maintenance therapy with strong long-term evidence.
Pricing ranges from $20 to $80 per month depending on whether the prescription is oral, topical, or a compounded multi-active.
Rankings combine clinical formulary depth, pricing transparency, and shipping reliability — weighted equally and reviewed quarterly. Read the full methodology →
Providers That Prescribe online
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
Publicly traded telehealth giant with weight-loss, ED, and hair-loss programs under one roof.
Affordable men's health clinic specialised in TRT and weight loss with transparent pricing.
Women-focused sister brand to Hims spanning GLP-1, hair, skincare, and menopause care.
Online doctor's office and pharmacy with 48-hour delivery and no required virtual visit in most states.
Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.
Medically supervised, discreet, multi-category telehealth with a heavy compounded formulary.
Custom-compounded, rapid-dissolve treatments for men's health with transparent pricing and free provider visits.
What the Studies Actually Show
Finasteride 1 mg/day is the FDA-approved oral therapy for male pattern hair loss. Compounded multi-active topicals (often combining finasteride with minoxidil and other actives) build on this evidence but have not themselves been studied in head-to-head trials. Figures below come from the pivotal RCTs and the FDA prescribing information.
| Endpoint | Finding |
|---|---|
| Hair regrowth (Kaufman et al., 2-year RCT)1 | Finasteride 1 mg/day produced visible hair regrowth in 48% of men at 1 year and 66% at 2 years vs 7% with placebo |
| Long-term efficacy (5-year follow-up)2 | 90% of men treated with finasteride 1 mg/day either maintained or increased hair count at 5 years |
| Mechanism3 | Selective 5-alpha-reductase type II inhibitor; reduces serum dihydrotestosterone (DHT) by ~70% at 1 mg/day |
| Sexual side effects (FDA prescribing information)3 | Decreased libido 1.8%, erectile dysfunction 1.3%, decreased ejaculate volume 0.8% — vs placebo rates of 1.3%, 0.7%, and 0.4% Persistent post-finasteride syndrome (PFS) has been reported in a minority of users. The FDA updated the Propecia label in 2012 to acknowledge persistent sexual adverse events; population frequency remains uncertain. |
- Kaufman KD et al. — J Am Acad Dermatol 1998 · Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578–589.
- 5-year follow-up — Eur J Dermatol 2002 · Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss. Eur J Dermatol 2008;18(4):400–406.
- FDA Prescribing Information — Propecia (finasteride) · PROPECIA (finasteride) tablets, 1 mg. U.S. Food and Drug Administration prescribing information.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.